Spending on cancer drugs in the United States has now exceeded $56 billion and the median annual cost of a new cancer...
Prior Authorizations are designed to ensure that patients receive the right care at the right time, and in the most...
Continued Relationships with Health Insurers Reflect the Need for High-quality, High-value Care as Cancer Treatments Become Increasingly Complex Culver City,...
NantHealth Presented These Findings at the ASCO 2020 Gastrointestinal Cancers Symposium San Francisco, CA – January 25, 2020: NantHealth, Inc....
Learn how payers can curb out-of-control cancer costs and address the inevitable swing to consumer-driven approaches to care. This webcast...
Innovative new treatments and advanced therapies have provided a fundamental shift in oncology care. This evolution has transformed outcomes for...
Biosimilars are becoming quite the buzzword in cancer treatment, but cost, regulation, safety and efficacy are driving questions amongst payers...
Cancer care is costly and complex; and if you don’t have the tools needed to effectively manage your cancer spend,...
This designation reaffirms that NantHealth is a trusted leader in utilization review and is committed to quality and transformative healthcare,...